CRISPR Therapeutics AG (CRSP)
68.16
-2.00
(-2.85%)
USD |
NASDAQ |
Mar 28, 16:00
68.25
+0.09
(+0.13%)
After-Hours: 20:00
CRISPR Therapeutics Cash and Short Term Investments (Quarterly): 1.694B for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.694B |
September 30, 2023 | 1.740B |
June 30, 2023 | 1.768B |
March 31, 2023 | 1.883B |
December 31, 2022 | 1.815B |
September 30, 2022 | 1.896B |
June 30, 2022 | 2.065B |
March 31, 2022 | 2.221B |
December 31, 2021 | 2.379B |
September 30, 2021 | 2.477B |
June 30, 2021 | 2.589B |
March 31, 2021 | 1.806B |
December 31, 2020 | 1.690B |
September 30, 2020 | 1.366B |
June 30, 2020 | 945.07M |
March 31, 2020 | 889.71M |
Date | Value |
---|---|
December 31, 2019 | 943.77M |
September 30, 2019 | 629.72M |
June 30, 2019 | 427.88M |
March 31, 2019 | 437.55M |
December 31, 2018 | 456.65M |
September 30, 2018 | 487.30M |
June 30, 2018 | 319.74M |
March 31, 2018 | 341.77M |
December 31, 2017 | 239.76M |
September 30, 2017 | 253.52M |
June 30, 2017 | 272.26M |
March 31, 2017 | 288.87M |
December 31, 2016 | 315.52M |
September 30, 2016 | 228.61M |
June 30, 2016 | 246.85M |
December 31, 2015 | 155.96M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
427.88M
Minimum
Jun 2019
2.589B
Maximum
Jun 2021
1.583B
Average
1.754B
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Vertex Pharmaceuticals Inc | 11.22B |
Intellia Therapeutics Inc | 912.22M |
Roche Holding AG | 12.51B |
Novartis AG | 13.96B |
bluebird bio Inc | 174.29M |